[1]
D. G. Oke, O. A. Olalekan, E. F. Olujinmi, J. O. Aworinde, and A. K. Oyebamiji, “Theoretical bio-investigation of 3-(benzo[d]thiazol-2-yl)-2-(substituted aryl)thiazolidin-4-one derivatives as potential Mycobacterium tuberculosis H37Rv inhibitors”, Eclét. Quím., vol. 50, p. e–1550, Dec. 2025.